CDRH Slows Pace In 2011 Strategic Agenda, Focusing On Ongoing Efforts
This article was originally published in The Gray Sheet
Executive Summary
In 2011, FDA's device center will focus largely on continuing or completing initiatives begun last year, including 510(k) reform, device reclassifications and interactive review improvements, according to the agency.
You may also be interested in...
FDA Kicks Off 510(k) Reform Plan, Punts Some Decisions To IOM
FDA’s plan for improving its 510(k) pre-market submission program includes clarifying instances where clinical data should be included and streamlining its “de novo” review process for certain innovative, lower-risk devices.
MDMA Grows Its Ranks, Digs In On FDA Reform Process
On the backdrop of health care reform and other changes in Washington, D.C., the Medical Device Manufacturers Association is seeing "significant growth," the group's president and CEO Mark Leahey said in an interview
FDA Brainstorms New Regulatory Models To Address Unmet Health Needs
FDA is considering some "out-of-the-box" ways to get needed device technologies in doctors' hands faster while still ensuring patient safety